Skip to main content

Evidence Sync CVE-2018-17538

CRITICAL
2018-09-26 cve@mitre.org
9.8
CVSS 3.0 · NVD
Share

Severity by source

NVD PRIMARY
9.8 CRITICAL
AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Attack Vector
Network
Attack Complexity
Low
Privileges Required
None
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

Lifecycle Timeline

1
CVE Published
Sep 26, 2018 - 08:29 nvd
CRITICAL 9.8

DescriptionNVD

Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability

AnalysisAI

Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability Affected products include: Axon Evidence Sync.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

Share

CVE-2018-17538 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy